Patient / Diagnostic Journey Mapping

As the precision medicine technologies and treatments evolve, so does the patient journey. Understanding how your products and services fit into the patient journey, and the barriers or challenges you may face, is critical to realizing your market potential.

Our Experts

Andrew Aijian

Stephane Budel

Miguel Edwards

Schedule a Call

Related Client Results

All Client Results

Synthetic Oligonucleotides Market Sizing

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

No items found.

Clinical Diagnostics

MRD Monitoring Market Assessment and Strategy

A diagnostics player wanted to determine with indications / use cases to target and develop a product road map

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Market Landscaping and Sizing

Pharma & Biotech

Biopharma Genomic Testing Market Research

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx

Voice-of-Customer Research

Clinical Diagnostics

Low-Throughput Molecular Diagnostic Testing Landscape Assessment

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

Target Identification

Pre-due Diligence Research on a Potential Acquisition Target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Due Diligence

Target Identification

Precision Medicine is evolving at a rapid pace

Discover how we can help